On Friday, Total SA (ADR) (NYSE:TOT)’s shares inclined 1.41% to $50.44.
The Board of Directors of Total met on July 28, 2015, and approved a second quarter 2015 interim dividend of 0.61 euros per share. This interim dividend, unchanged contrast to the first quarter of 2015, is payable in euros according to the following timetable:
Ex-dividend date December 21, 2015
Record date December 18, 2015
Payment date in cash or shares issued in lieu of cash January 14, 2016
TOTAL S.A. operates as an oil and gas company worldwide. The company operates through three segments: Upstream, Refining & Chemicals, and Marketing & Services. The Upstream segment explores and produces oil and gas; ships, trades, and markets natural gas, liquefied natural gas, and liquefied petroleum gas (LPG); generates power; and mines and markets coal.
EASY ST50 EUROP A (NYSE:ETN)’s shares dropped -0.07% to $59.93.
The Board of Directors of power administration company Eaton (ETN) declared a quarterly dividend of $0.55 per ordinary share payable August 21, 2015 to shareholders of record at the close of business on August 3, 2015.
For U.S. tax purposes, Eaton estimates that all of the 2015 dividend will be treated as a return of capital to shareholders, to the extent of the shareholder’s tax basis in the shares. Additional information about the tax treatment of the dividend, counting actual return of capital information for 2014, is accessible at the investor relations page of the Eaton website, www.Eaton.com.
Eaton Corporation plc operates as a power administration company worldwide. Its Electrical Products segment offers electrical components, industrial components, residential products, wiring devices, and structural support systems, in addition to single phase power quality, emergency lighting, fire detection, circuit protection, and lighting products. The company’s Electrical Systems and Services segment provides power distribution and assemblies, three phase power quality products, hazardous duty electrical equipment, intrinsically safe explosion-proof instrumentation, utility power distribution products, power reliability equipment, and services.
At the end of Friday’s trade, TASER International, Inc. (NASDAQ:TASR)‘s shares dipped -2.54% to $23.98.
TASER International, Inc. (TASR), declared financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Financial Highlights:
- Net sales were $46.7 million in the quarter, an enhance of $9.5 million, or 25.7%, contrast to second quarter 2014 net sales of $37.2 million. International sales were $8.0 million in the quarter, an enhance of $3.0 million contrast to the preceding year second quarter.
- TASER Weapons segment revenues grew $5.2 million year-over-year, or 15.8%, to $37.8 million in the second quarter of 2015. The enhance in Smart Weapon sales of $7.5 million was partially offset by a decrease of $3.1 million in sales of legacy TASER X26 CEW, which was stepped down from production as of December 31, 2014.
- Axon segment revenues raised by $4.4 million, or 97.5%, to $8.9 million in the second quarter of 2015 in comparison to the preceding year second quarter. The enhance was partially driven by a $2.1 million enhance, or 226.1%, in service revenue contrast to the second quarter 2014 which was driven by raised license counts and higher monthly per license revenues for Evidence.com in addition to raised professional services delivered. Axon body-worn camera hardware sales raised $1.7 million contrast to the preceding year period as more agencies embraced this technology.
TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The company’s CEW products transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. It offers three hand-held CEW product lines, counting TASER X26P and TASER X2, which integrates with EVIDENCE.com; and TASER X26.
China Cord Blood Corp (NYSE:CO), ended its Friday’s trading session with 3.14% gain, and closed at $6.90.
China Cord Blood Corporation (CO) China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, declared that its board of directors has received a non-binding acquisition proposal letter from Nanjing Xinjiekou Department Store Co., Ltd. (the “Potential Acquirer”), following which the Potential Acquirer offered to acquire all the Company’s China business, counting all of the Company’s equity interests in its China auxiliaries and its assets and resources regardingits business in China (the “Proposal”). The purchase price offered is not lower than RMB6.0 billion, to be paid in cash or shares or a combination thereof.
The special committee of the Company’s board of directors, in consultation with its legal and financial advisors, will carefully review and evaluate the Proposal. The Company cautions its shareholders and others considering trading its ordinary shares that no decisions have been made with respect to the Company’s response to the Proposal. There can be no assurance that any agreement will be executed or that this or any other transaction will be approved or consummated.
China Cord Blood Corporation, together with its auxiliaries, primarily provides umbilical cord blood storage and ancillary services in the People’s Republic of China. The company provides cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, in addition to offers matching services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
